TM
SANA icon

Torren Management’s Sana Biotechnology SANA Stock Holding History

Torren Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-191
Closed -$777 – 1374
2025
Q4 		$777 Buy
+191
New +$855 ﹤0.01% 1249

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Torren Management's SANA Position: Q1 2026 in Review

Torren Management sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 191 shares — an estimated $777 sold.

Torren Management first reported a position in SANA in Q4 2025 and held it in 1 quarter. The position peaked at $777 in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Torren Management reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 191 Sana Biotechnology shares in Q1 2026, an estimated $777.
  • Torren Management first reported a position in Sana Biotechnology in Q4 2025 and held it in 1 quarter.
  • Torren Management's Sana Biotechnology position peaked at $777 in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.